For all our research and awards news, please visit our news page.
Monday, 12 February 2018
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Eric Morand et al. published in Annals of the Rheumatic Diseases.
Eric Morand et al. published in Annals of the Rheumatic Diseases.
No comments:
Post a Comment